PharVision Advisers’s Kohl's KSS Stock Holding History

PharVision Advisers’s Portfolio KSS Stock Details KSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,957	Closed	-$169K	–	732
2025 Q2	$169K	Buy	+19,957	New	+$153K	0.24%	221

Other funds holding KSS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's KSS Position: Q3 2025 in Review

PharVision Advisers sold out of Kohl's (KSS) in Q3 2025, closing a stake of 19,957 shares — an estimated $169K sold.

PharVision Advisers first reported a position in KSS in Q2 2025 and held it in 1 quarter. The position peaked at $169K in Q2 2025. 338 funds tracked by Wall St. Rank hold KSS as of Q3 2025.

PharVision Advisers reported no remaining Kohl's position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 19,957 Kohl's shares in Q3 2025, an estimated $169K.
PharVision Advisers first reported a position in Kohl's in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Kohl's position peaked at $169K in Q2 2025.
338 funds tracked by Wall St. Rank held Kohl's as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.